Synthesis 2003(13): 1989-1994
DOI: 10.1055/s-2003-41039
PAPER
© Georg Thieme Verlag Stuttgart · New York

Synthesis of Dinucleotide Thiophosphoramidates as Anti-HIV New Prodrugs

Changxue Lina, Hua Fu*a, Guangzhong Tub, Yufen Zhao*a
a The Key Laboratory of Bioorganic Phosphorus Chemistry, Ministry of Education, Department of Chemistry, School of Life Sciences and Engineering, Tsinghua University, Beijing 100084, P. R. China
Fax: +86(10)62781695; e-Mail: fuhua@mail.tsinghua.edu.cn ;
b Beijing Institute of Microchemistry, Beijing 100091, P. R. China
Further Information

Publication History

Received 6 May 2003
Publication Date:
28 August 2003 (online)

Abstract

Sequential transesterification of diphenyl phosphite with 5′-O-(4,4′-dimethoxytrityl)thymidine (1) and hydrogen sulfide gave O-[5′-O-(4,4′-dimethoxytrityl)thymidine-3′-yl] H-thiophosphonate (2), and subsequent condensation of 2 with AZT or d4T in the presence of diphenyl chlorophosphoate provided the dinucleotide H-thiophosphonates 3 or 3′. The Antherton-Todd reaction of 3 or 3′ with l-amino acid methyl ester in a solution of CCl4-Et3N-H2O-MeCN gave the dinuleotide thiophosphoramidates 4 or 4′, and removal of the dimethoxytrityl protecting group in formic acid yielded the target products AZT/d4T thiophosphoramidates 5 and 5′.

    References

  • 1 Ueno T. Mitsuya H. Clin. Immunother.  1995,  4:  451 
  • 2 Boussard C. Doyle VE. Mahmood N. Klimkait T. Pritchard M. Gilbert IH. Eur. J. Med. Chem.  2002,  37:  883 
  • 3a Vlieghe P. Clerc T. Pannecouque C. Witvrouw M. De Clercq E. Salles JP. Kraus JL. J. Med. Chem.  2002,  45:  1275 
  • 3b Wong A. Toth I. Curr. Med. Chem.  2001,  8:  1123 
  • 3c Gallo JM. Adv. Drug Deliver Rev.  1994,  14:  199 
  • 4a Mitsuya H. Weinhold KJ. Furman PA. Clair MH. Proc. Natl. Acad. Sci. U. S. A.  1985,  82:  7096 
  • 4b Rando RF. Nguyen-Ba N. Drug Discovery Today  2000,  5:  465 
  • 4c Fischl MA. Richman DD. Grieco MH. Gottlieb MS. N. Engl. J. Med.  1987,  317:  185 
  • 5 Wanger CR. Iyer VV. McIntee E. J. Med. Res. Rev.  2000,  20:  417 
  • 6a Richman DD. Fischl MA. Grieco MH. Gottlieb MS. Volberding PA. Laskin OL. Leedon JM. Groopman JE. Mildvan D. Hirsch MS. Jackson GG. Durack DT. Nusinoff-Lehrman S. N. Engl. J. Med.  1987,  317:  192 
  • 6b Pan-Zhou XR. Cretton-Scott E. Zhou XJ. Yang MX. Lasker JM. Sommadossi JP. Biochem. Pharmacol.  1998,  55:  757 
  • 6c Trapnell CB. Klecker RW. Jamisdow C. Collins JM. Antimicrob. Agents. Chemother.  1998,  42:  1592 
  • 7a Larder BA. Darby G. Richman DD. Science  1989,  243:  1731 
  • 7b Kallam P. Boucher CAB. Larde BA. Proc. Natl. Acad. Sci. U. S. A.  1992,  89:  1934 
  • 7c Rando RF. Nguyen-Ba N. Drug Discovery Today  2000,  5:  465 
  • 8a Parang K. Wiebe LI. Knaus EE. Curr. Med. Chem.  2000,  7:  995 
  • 8b Sergheraert C. Pierlot C. Tartar A. Henin Y. Lemaitre M. J. Med. Chem.  1993,  36:  826 
  • 8c Hostetler KY. Stuhmiller LM. Lenting HBM. van den Bosch H. Richman DD. J. Biol. Chem.  1990,  265:  6112 
  • 9 Busso M. Mian AM. Hahn EF. Resnick L. AIDS Res. Hum. Retroviruses  1988,  4:  449 
  • 10 Shinazi RF. Sommadossi JP. Saalmann V. Cannon DL. Xie MY. Hart GC. Smith GA. Hahn EF. Antimicrob. Agents Chemother.  1990,  34:  1061 
  • 11 De Clerq E. Nucleosides Nucleotides Nucleic Acids  1994,  13:  1271 
  • 12 Stein CA. Nucleic Acids Res.  1988,  16:  3209 
  • 13a McGuigan C. Devine KG. O’Connor TJ. Galpin SA. Jeffries JD. Kinchington D. Antiviral Chem. Chemother.  1990,  1:  107 
  • 13b McGuigan C. Devine KG. O’Connor TJ. Kinchington D. Antiviral Res.  1991,  15:  255 
  • 14a Atherton FR. Openshaw HT. Todd AR. J. Chem. Soc.  1945,  660 
  • 14b Atherton FR. Todd AR. J. Chem. Soc.  1947,  674 
  • 15 Peyser JR. Ferris JP. Orig. Life Evol. Biosph.  2001,  31:  363 
  • 16 Kers I. Kers A. Stawinski J. Tetrahedron Lett.  1999,  40:  3945